BridgeMD
New treatment option for Lymphoma
Official title Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
ClinicalTrials.gov ID: NCT06660446
What this study is testing
- What it's testing
- In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty There is an association between some biological biomarkers with physical capacity and frailty.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age: ≥18 years old.
- Diagnosis of lymphoma with histological confirmation and requirement of systemic treatment including chemotherapy.
- Time available (80 minutes, two days a week for 20 weeks) to carry out physical exercise sessions.
- Have a mobile phone to be able to contact the person and download the physical activity level app.
- Eastern Cooperative Oncology Group performance status (ECOG) ≤2.
You likely can't join if
- Have a contraindication to moderate-high intensity exercise.
- Other significant medical disorders: including psychiatric illnesses chronic or recurrent; intellectual disability, musculoskeletal problems, cardiac...
- Have plans to be outside city more than two weeks.
- People who are already physically active (that comply with the recommendations of WHO: \> 150 minutes of exercise moderate/weekly, plus training...
- Treatment based only with immunotherapy.
- Central nervous system involvement due to lymphoma.
See the full eligibility criteria
- Age: ≥18 years old.
- Diagnosis of lymphoma with histological confirmation and requirement of systemic treatment including chemotherapy.
- Time available (80 minutes, two days a week for 20 weeks) to carry out physical exercise sessions.
- Have a mobile phone to be able to contact the person and download the physical activity level app.
- Eastern Cooperative Oncology Group performance status (ECOG) ≤2.
- Life expectancy \>12 months.
- Availability and desire to participate throughout the study period.
- Have a contraindication to moderate-high intensity exercise.
- Other significant medical disorders: including psychiatric illnesses chronic or recurrent; intellectual disability, musculoskeletal problems, cardiac or pulmonary disorders that interfere with physical exercise; other...
- Have plans to be outside city more than two weeks.
- People who are already physically active (that comply with the recommendations of WHO: \> 150 minutes of exercise moderate/weekly, plus training force two days/week).
- Treatment based only with immunotherapy.
- Central nervous system involvement due to lymphoma.
- Have any important history that limit the capacity of the patient to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Vitoria - Gateiz, Araba, Spain
- Galdakao, Bizkaia, Spain
- San Sebastián, Guipuzcoa, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vitoria - Gateiz, Araba, Spain; Galdakao, Bizkaia, Spain; San Sebastián, Guipuzcoa, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.